Abstract |
Breast cancer, melanoma and glioblastoma cells undergo cell-mediated aggregation and aggregate coalescence in a transparent 3D Matrigel environment. Cells from normal tissue and non-tumorigenic cell lines do not exhibit these behaviors. Here, 266 monoclonal antibodies (mAbs) demonstrated to interact with a wide variety of membrane, secreted and matrix proteins, have been screened for their capacity to block these tumorigenic cell-specific behaviors in a 3D environment. Remarkably, only six of the 266 tested mAbs exhibited blocking activity, four targeting integrin ß-1, one targeting integrin α-3 and one targeting CD44. Colocalization of integrins ß-1 and α-3 in fixed cells and in live aggregates suggests that the integrin α-3 ß-1 dimer plays a central role in cancer cell aggregation in the 3D environment provided by Matrigel. Our results suggest that blocking by anti- integrin and anti-CD44 mAbs involves interference in cell-cell interactions.
|
Authors | Daniel F Lusche, Michael R Klemme, Benjamin A Soll, Ryan J Reis, Cristopher C Forrest, Tiffany S Nop, Deborah J Wessels, Brian Berger, Rebecca Glover, David R Soll |
Journal | mAbs
(MAbs)
2019 May/Jun
Vol. 11
Issue 4
Pg. 691-708
ISSN: 1942-0870 [Electronic] United States |
PMID | 30810437
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Blocking
- Antibodies, Monoclonal
- CD44 protein, human
- Drug Combinations
- Hyaluronan Receptors
- Integrin alpha3beta1
- Laminin
- Proteoglycans
- matrigel
- Collagen
|
Topics |
- Antibodies, Blocking
(metabolism)
- Antibodies, Monoclonal
(metabolism)
- Breast Neoplasms
(metabolism, pathology)
- Cell Adhesion
- Cell Aggregation
- Cell Line, Tumor
- Cell Movement
- Collagen
- Drug Combinations
- Female
- Glioblastoma
(metabolism, pathology)
- Humans
- Hyaluronan Receptors
(immunology, metabolism)
- Integrin alpha3beta1
(immunology, metabolism)
- Laminin
- Melanoma
(metabolism, pathology)
- Proteoglycans
|